Posted by Michael Wonder on 29 Jan 2018
Brexit Alliance calls for Brexit deal on medicines regulation
29 January 2018 - The Brexit Health Alliance is again warning that medicines supply in the UK is in danger of being disrupted if the issue of co-operative regulation is not addressed during Brexit negotiations.
According a its new briefing paper, Brexit and the impact on patient access to medicines and medical technologies, unless a deal access to some treatments could be delayed or even become unavailable to patients.
“Shared regulatory frameworks at EU level have been crucial in providing patients with faster access to treatments,” it stresses, arguing that “in the global market, separate national systems of regulation of health technologies can slow down treatments for patients”.
